Alzheimer’s disease (AD) is a neurodegenerative illness affecting (with other dementias) approximately 500,000 Floridian’s causing progressive forgetfulness and other cognitive dysfunctions. It is suspected that it is caused by the accumulation in a brain of abnormal protein called amyloid. It is estimated that the deposition of the amyloid in a brain starts 5-10 years before the first symptoms of memory problems are noticed by the patient or his/her family. Recently, the amyloid detection nuclear imaging has been approved by the FDA for use in clinical settings.
Traumatic Brain Injury (TBI) which may cause memory and cognitive problems is one of the conditions which responds well to LORETA Neurofeedback. This type of neurofeedback is also used by the US Army as a therapy for soldiers after TBI injury in combat.
Dizziness is a common, frequently chronic, and often untreated symptom, associated with extensive handicap and psychological morbidity.
Balance and vestibular disorders are poorly understood by many primary providers and often mismanaged. Many patients with dizziness are needlessly subjected to unnecessary tests and medications. This process results in costly and frustrating care for the patient. Patients with vertigo or imbalance could be diagnosed and treated effectively at one location in the most cost-efficient manner.
Headaches-frequently are occuring on a daily basis and are disabling. Neurofeedback has been shown to be an effective treatment modality of chronic headaches.
Epilepsy is a common neurological disorder causing intermittent confusion and frequently loss of the consciousness. QEEG(brain mapping) has been an effective tool in epileptic seizure detection.
ADHD/ADD and Autistic Spectrum Disorder (ASD) patients usually have abnormal QEEG (brain maps) and frequently respond to Neurofeedback therapy.